Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer

詳細情報 詳細情報について

• CRID

  1361699994622348160

• DOI

  10.1007/s00280-015-2850-4

• ISSN

  14320843

  03445704

• Web Site

  http://link.springer.com/content/pdf/10.1007/s00280-015-2850-4.pdf

  http://link.springer.com/article/10.1007/s00280-015-2850-4/fulltext.html

  http://link.springer.com/content/pdf/10.1007/s00280-015-2850-4

• データソース種別

  • Crossref